Treatment of Intermittent Claudication with Antiplatelet Agents

Journal of International Medical Research

Volumn 18, Issue 5, 1990, Pages 400-407

  Giansante, C ^a   Calabrese, S ^a   Fisicaro, M ^a   Fiotti, N ^a   Mitri, E ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Trieste General Hospital   (Italy)

Author keywords

aspirin; dipyridamole; intermittent claudication; platelet aggregation; Ticlopidine; xanthinol nicotinate

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; TICLOPIDINE; XANTHINOL NICOTINATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; EPISTAXIS; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; THROMBOCYTE AGGREGATION;

ADULT; ANTITHROMBIN III; ASPIRIN; BETA-THROMBOGLOBULIN; CALCIUM; DIPYRIDAMOLE; DOUBLE-BLIND METHOD; FEMALE; FIBRINOPEPTIDE A; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; XANTHINOL NIACINATE;

EID: 0025095954     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006059001800508     Document Type: Article

References (25)

1. Dormandy JA Mahir MS : The natural history of peripheral atheromatous disease of legs. In: Vascular Surgery – Issues in Current Practice (Greenhalgh RM Jamieson CW Nicolaides AN, eds). Orlando: Grune & Stratton, 1986; pp 3–17.
2. Ross R Glomset JA : The pathogenesis of atherosclerosis. N Engl J Med 1976; 295: 369–376.
3. Rutherford RB Ross R : Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol 1976; 69: 196–203.
4. Zahavi J Zahavi M : Enhanced platelet release reaction, shortened platelet survival and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Thromb Haemost 1985; 53: 105–109.
5. Cella G Zahavi J De Haas HA : Betathromboglobulin platelet production time and platelet function in vascular disease. Br J Haematol 1979; 43: 127–136.
6. Calabrese S Giansante C Da Col PG : Evaluation of some pharmacological effects on platelets and coagulation in lower limbs arteriopathy. G Arterioscl 1984; 9: 223–235.
7. Roeschlau P Bernt E Gruber W : Enzymatische Bestimmung des gesamt Cholesterins in Serum. Z Klin Chem Biochem 1974; 12: 403–407.
8. Schmidt FH Von Dahl K : Zur Methode der enzymatische neutral fett Bestimmung in biologischen Material. Z Klin Chem Biochem 1968; 6: 156–159.
9. Lipid Research Clinics Program: Manual of Lipid Operation. Vol. 1. Lipid and Lipoprotein Analysis. Department of Health Education and Welfare Publication, No. (NIH) 75–628; 1974.
10. Born GVR : Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–992.
11. Ludlam CA Moore S Bolton AE : The release of a human platelet specific protein measured by radio-immunoassay. Thromb Res 1975; 5: 543–548.
12. Nossel HL Yudelman I Calfield RE : Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43–53.
13. Odegard OR Lie M Abilgaard U : Heparin cofactor activity measured with amidolytic method. Thromb Res 1975; 6: 287–294.
14. Reid HL Barnes AJ Lock PJ : A simple method for measuring erythrocyte deformability. J Clin Pathol 1976; 29: 855–858.
15. Cordaro C Carandente O : Esperienze pratiche sulla metodica di filtrazione eritrocitaria. Ric Clin Lab 1980; 10 (suppl 1): 113–126.
16. Bruno JJ : The mechanism of action of ticlopidine. Thromb Res 1983; 4 (suppl): 75–80.
17. Mustard JF Packham MA : Platelets, thrombosis and drugs. Drugs 1975; 9 (1): 19–76.
18. Asano T Ochiai Y Hidaka H : Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors. Mol Pharmacol 1977; 13: 400–406.
19. Masotti G Poggesi L Galanti G : Stimulation of prostacyclin by dipyridamole. Lancet 1979; i: 1412.
20. Moncada S Korbut R : Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1978; i: 1286–1289.
21. Gryglewski RJ : Prostaglandins, platelets and atherosclerosis. CRC Crit Rev Bicochem 1980; 7: 291–339.
22. Green K Vesterqvist O : In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC – MS measurements of major urinary metabolites. Adv Prostaglandin Thromboxane Leukotriene Res 1986; 16: 309–324.
23. Rasmanis G Vesterqvist O Green K : Effects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction. Lancet 1988; ii: 245–247.
24. Coffman JD : Vasodilators in peripheral vascular disease. N Engl J Med 1979; 300: 713–716.
25. Di Perri T : Emoreologia e trombosi(Abstract). III Congresso Nazionale della Società Italiana di Emoreologia, Florence, 4–6 February 1988; pp 36–37.